Restenosis Management: The Emerging Role of Drug-Coated Balloons
The treatment of coronary artery disease (CAD) has undergone remarkable transformation over the recent decades reflecting major advancements in interventional cardiology. The field has transitioned from highly invasive open-heart surgeries to minimally invasive procedures that improve safety, efficacy, and patient recovery. Advances in percutaneous coronary intervention (PCI), particularly with drug-eluting stents (DES) have significantly improved […]
DCB Digest Edition 2
World Heart Day 2025: Translumina’s Commitment to Reducing the Global Impact of Heart Disease
Every year on 29th September, millions of people observe World Heart Day, a global initiative to raise awareness about cardiovascular disease (CVD), the world’s leading cause of death. More than just a health observance, it serves as a powerful call to action, urging individuals, families, and healthcare systems to prioritize heart health through informed choices […]
What Are Drug-Eluting Stents and How Do They Work?
Heart disease remains one of the leading health challenges worldwide. One common problem is the narrowing of coronary arteries, which reduces the blood supply to the heart and can lead to chest pain, shortness of breath, or even a heart attack. To treat this, doctors often use a small device called a stent to keep […]
How Safe Are Drug-Eluting Stents? Key Insights Every Cardiologist Should Know
When patients hear they need a stent for heart blockage, one question usually follows: are drug-eluting stents safe? For doctors, this is not just a patient query but a practical concern during every procedure. Drug-eluting stents (DES) are now a common tool used in treating narrowed coronary arteries. Their safety has been debated for years, […]
DCB Digest Edition 1
